Circumcision-related HIV Risk and the Unknown Mechanism of Effect in the Male Circumcision Trials

Annals of Epidemiology

Volumn 17, Issue 11, 2007, Pages 928-929

  Brewer, Devon D ^a   Potterat, John J ^b   Roberts Jr , John M ^c   Brody, Stuart ^d  

^a Interdisciplinary Scientific Research   (United States)

^b University of New Mexico ^*

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; CIRCUMCISION; CLINICAL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYGIENE; INFECTION RISK; JUVENILE; LETTER; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS; SURGICAL RISK; VIRUS TRANSMISSION;

EID: 35348884219     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.08.001     Document Type: Letter

References (16)

1. Westreich D, Rennie S, Muula A. Comments on Brewer et al. "Male and female circumcision associated with prevalent HIV infection in virgins and adolescents in Kenya, Lesotho, and Tanzania." Ann Epidemiol 2007 Jun 5 [Epub ahead of print].
2. Adams J., Trinitapoli J., and Poulin M. Response to Brewer et al. Ann Epidemiol 17 (2007) 923-925
3. Brewer D.D., Potterat J.J., Roberts Jr. J.M., and Brody S. Male and female circumcision associated with prevalent HIV infection in virgins and adolescents in Kenya, Lesotho, and Tanzania. Ann Epidemiol 17 (2007) 217-226
4. Mensch B.S., Hewett P.C., and Erulkar A.S. The reporting of sensitive behaviors by adolescents: a methodological experiment in Kenya. Demography 40 (2003) 247-268
5. Cowan F.M., Langhaug L.F., Mashungupa G.P., Nyamurera T., Hargrove J., Jaffar S., et al. School based HIV prevention in Zimbabwe: feasibility and acceptability of evaluation trials using biological outcomes. AIDS 16 (2002) 1673-1678
6. Gregson S., Nyamukapa C.A., Garnett G.P., Mason P.R., Zhuwau T., Carael M., et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 359 (2002) 1896-1903
7. Plummer M.L., Ross D.A., Wight D., Changalucha J., Mshana G., Wamoyi J., et al. "A bit more truthful": the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods. Sex Transm Infect 80 Suppl 2 (2004) ii49-ii56
8. Ryder K.W., Munsick R.A., Oei T.O., Young P.C., and Blackford H.F. Five recent urinary tests for early pregnancy evaluated. Clin Chem 29 (1983) 1812-1814
9. Peeling R.W., Toye B., Jessamine P., and Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect 74 (1998) 66-70
10. Naryshkin S., Aw T.C., Filstein M., Murphy J.G., Strauss III J.F., Kiechle F.L., et al. Comparison of the performance of serum and urine hCG immunoassays in the evaluation of gynecologic patients. Ann Emerg Med 14 (1985) 1074-1076
11. Brewer D.D., Potterat J.J., Muth S.Q., and Brody S. Converging evidence suggests nonsexual HIV transmission among adolescents in sub-Saharan Africa. J Adolesc Health 40 (2007) 290-291
12. Auvert B., Taljaard D., Lagarde E., Sobngwi-Tambekou J., Sitta R., and Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2 (2005) e298
13. Bailey R.C., Moses S., Parker C.B., Maclean I., Krieger J.N., Williams C.F.M., et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 (2007) 643-656
14. Gray R.H., Kigozi G., Serwadda D., Makumbi F., Watya S., Nalugoda F., et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369 (2007) 657-666
15. Weiss H.A., Thomas S.L., Munabi S.K., and Hayes R.J. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 82 (2006) 101-109
16. de Witte L., Nabatov A., Pion M., Fluitsma D., de Jong M.A., de Gruijl T., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13 (2007) 367-371